Minimizing Repolarization-Related Proarrhythmic Risk in Drug Development and Clinical Practice

ISSN： 0012-6667

Source： Drugs, Vol.70, Iss.5, 2010-03, pp. : 573-603

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quinidine elicits proarrhythmic changes in ventricular repolarization and refractoriness in guinea-pig

Canadian Journal of Physiology and Pharmacology, Vol. 91, Iss. 4, 2013-01 ,pp. : 306-315

NRC Research Press

Access to resources Recommend Favorite

Drug-related problems in general practice: results from a development project in Denmark

By Soendergaard Birthe Kirkeby Bente Dinsen Christine Herborg Hanne Kjellberg Jakob Staehr Peter

Pharmacy World and Science, Vol. 28, Iss. 2, 2006-04 ,pp. : 61-64

Springer Publishing Company

Access to resources Recommend Favorite

Personalised medicine for cancer: from drug development into clinical practice

By Jain K K

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1463-1476

Informa Healthcare

Access to resources Recommend Favorite

Understanding Developmental Pharmacodynamics: Importance for Drug Development and Clinical Practice

By Mulla Hussain

Pediatric Drugs, Vol. 12, Iss. 4, 2010-08 ,pp. : 223-233

Adis International

Access to resources Recommend Favorite

Development and Validation of a Prognostic Index for Risk Stratification of Patients with Early Repolarization

By Stavrakis Stavros Patel Nishit Te Charles Golwala Harsh George Augustine Lozano Pedro Lazzara Ralph

Annals of Noninvasive Electrocardiology, Vol. 17, Iss. 4, 2012-10 ,pp. : 361-371

Blackwell Publishing

Access to resources Recommend Favorite